Synthetic method of bis-4-(1H-pyrazol-1-yl) piperidine-1-tert-butyl formate and application thereof

A technology of tert-butyl formate and synthesis method, which is applied in the synthesis of bis-4-piperidine-1-tert-butyl carboxylate and the synthesis of pharmaceutical intermediate impurities, which can solve the problem of increasing the difficulty of final product processing and affecting The purity of Nigerian medicines and other issues can be solved, and the effect of simple method and easy control of the process can be achieved

Active Publication Date: 2017-06-13
HEBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The study found that there is always an impurity in the synthesis process of crizotinib, and this impurity is accompanied by the synthesis of crizotinib drug intermediates, and will participate in and affect the subsequent reactions of the synthesis of crizotinib, resulting in More impurities are generated, which increases the difficulty of handling the final product and affects the purity of crizotinib
There is no report on the synthesis and structure of this impurity in the previous literature

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic method of bis-4-(1H-pyrazol-1-yl) piperidine-1-tert-butyl formate and application thereof
  • Synthetic method of bis-4-(1H-pyrazol-1-yl) piperidine-1-tert-butyl formate and application thereof
  • Synthetic method of bis-4-(1H-pyrazol-1-yl) piperidine-1-tert-butyl formate and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Example 1 The synthetic method of two-4-(1H-pyrazol-1-yl)piperidine-1-carboxylic acid tert-butyl ester

[0046] The present embodiment is a kind of synthetic method of bis-4-(1H-pyrazol-1-yl)piperidine-1-carboxylic acid tert-butyl ester, which is carried out according to the following steps:

[0047] (11) Mesylation reaction

[0048] Take 1mol N-Boc-4-hydroxypiperidine and dissolve it in MTBE / triethylamine mixed solution with a volume ratio of 10:1 at -10°C, add 1.3mol methanesulfonyl chloride (the manufacturer of methanesulfonyl chloride) dropwise Zhengzhou Haorong Chemical Products Co., Ltd.), keep warm for 2 hours after the dropwise addition; add water to quench the reaction, separate the organic phase, add a mixed solution of petroleum ether / n-heptane with a volume ratio of 62:38, and crystallize to obtain compound 1 -Boc-4-methanesulfonyloxypiperidine, denoted as A1;

[0049] The NMR image of A1 is as follows figure 1 As shown, the specific NMR data are as follo...

Embodiment 2-5

[0066] Example 2-5 The synthetic method of two-4-(1H-pyrazol-1-yl)piperidine-1-carboxylic acid tert-butyl ester

[0067] Embodiment 2-5 is respectively a kind of synthetic method of bis-4-(1H-pyrazol-1-yl)piperidine-1-carboxylic acid tert-butyl ester, and their synthetic method is similar to that of Example 1, the difference is only The reason is that the corresponding technical parameters are different during the synthesis process, see the table below for details.

[0068] Table 1 Technical parameter table

[0069]

Embodiment 6

[0070] Example 6 Suzuki coupling reaction condition screening test

[0071] In the process of preparing the target product, in the Suzuki coupling reaction process, the selection of solvent, reaction temperature, reaction time, alkali amount, and phase transfer catalyst dosage are important. In order to explore this condition, the following experiments were carried out in this embodiment:

[0072] Table 2-1 Suzuki coupling reaction condition parameter table

[0073]

[0074] Table 2-2 Parameter table of Suzuki coupling reaction conditions

[0075]

[0076] Table 2-3 Parameter table of Suzuki coupling reaction conditions

[0077]

[0078] Table 2-4 Parameter table of Suzuki coupling reaction conditions

[0079]

[0080] Table 2-5 Parameters of Suzuki coupling reaction conditions

[0081]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a synthetic method of bis-4-(1H-pyrazol-1-yl) piperidine-1-tert-butyl formate and an application thereof. The bis-4-(1H-pyrazol-1-yl) piperidine-1-tert-butyl formate is prepared through a methyl sulfonylation reaction, a hydrocarbylation reaction, a Grignard reaction and a Suzuki coupling reaction by taking cheap and easily available N-Boc-4-hydroxyl piperidine as a raw material. The synthetic method is simple, the process is easy to control, and the yield of the prepared bis-4-(1H-pyrazol-1-yl) piperidine-1-tert-butyl formate is 86.7%; bis-4-(1H-pyrazol-1-yl) piperidine-1-tert-butyl formate can be used as a standard substance to detect and monitor synthesis of crizotinib. The synthetic method disclosed by the invention is suitable for synthesizing bis-4-(1H-pyrazol-1-yl) piperidine-1-tert-butyl formate and the synthesized substance is used for detecting and monitoring synthesis of crizotinib.

Description

technical field [0001] The invention belongs to the field of pharmacy, and relates to a synthesis method of pharmaceutical intermediate impurities, in particular to a synthesis method of bis-4-(1H-pyrazol-1-yl)piperidine-1-carboxylic acid tert-butyl ester and a synthesis product of the corresponding synthesis application. Background technique [0002] In the process of drug synthesis, it is usually accompanied by the generation of impurities, and the research on impurities directly or indirectly affects the quality of the drug. The adverse reactions of the drug in clinical use are not only related to the pharmacological activity of the drug itself, but sometimes related to the drug itself. The presence of impurities also has a great relationship. Most impurities in drugs have potential biological activity and cytotoxicity. Therefore, the content of impurities may affect the safety and effectiveness of drugs, and even cause toxicity. The control of drug impurities plays a k...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D401/14G01N33/15
CPCC07D401/14G01N33/15
Inventor 束学野董新蕊王迎楠张越涂佳楠
Owner HEBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap